Cargando…
Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target
The antioxidative enzyme thioredoxin reductase (TrxR) has been suggested to be a drug target in several pathogens, including the protist parasite Giardia lamblia. TrxR is also believed to catalyse the reduction of nitro drugs, e.g. metronidazole and furazolidone, a reaction required to render these...
Autores principales: | Leitsch, David, Müller, Joachim, Müller, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971154/ https://www.ncbi.nlm.nih.gov/pubmed/27485086 http://dx.doi.org/10.1016/j.ijpddr.2016.07.003 |
Ejemplares similares
-
Drug Resistance in the Microaerophilic Parasite Giardia lamblia
por: Leitsch, David
Publicado: (2015) -
Physiological aspects of nitro drug resistance in Giardia lamblia
por: Müller, Joachim, et al.
Publicado: (2018) -
Comparative characterisation of two nitroreductases from Giardia lamblia as potential activators of nitro compounds
por: Müller, Joachim, et al.
Publicado: (2015) -
Metabolomic Profiling of Wildtype and Transgenic Giardia lamblia Strains by (1)H HR-MAS NMR Spectroscopy
por: Müller, Joachim, et al.
Publicado: (2020) -
Nitroreductase Activites in Giardia lamblia: ORF 17150 Encodes a Quinone Reductase with Nitroreductase Activity
por: Müller, Joachim, et al.
Publicado: (2021)